78 related articles for article (PubMed ID: 20600877)
1. Curcumin p38-dependently enhances the anticancer activity of valproic acid in human leukemia cells.
Chen J; Wang G; Wang L; Kang J; Wang J
Eur J Pharm Sci; 2010 Oct; 41(2):210-8. PubMed ID: 20600877
[TBL] [Abstract][Full Text] [Related]
2. Trichostatin A improves the anticancer activity of low concentrations of curcumin in human leukemia cells.
Chen J; Bai H; Wang C; Kang J
Pharmazie; 2006 Aug; 61(8):710-6. PubMed ID: 16964716
[TBL] [Abstract][Full Text] [Related]
3. Water-soluble antioxidants improve the antioxidant and anticancer activity of low concentrations of curcumin in human leukemia cells.
Chen J; Wanming D; Zhang D; Liu Q; Kang J
Pharmazie; 2005 Jan; 60(1):57-61. PubMed ID: 15700780
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional regulation of VCAM-1 expression by tumor necrosis factor-alpha in human tracheal smooth muscle cells: involvement of MAPKs, NF-kappaB, p300, and histone acetylation.
Lee CW; Lin WN; Lin CC; Luo SF; Wang JS; Pouyssegur J; Yang CM
J Cell Physiol; 2006 Apr; 207(1):174-86. PubMed ID: 16288471
[TBL] [Abstract][Full Text] [Related]
5. Curcumin-induced histone hypoacetylation: the role of reactive oxygen species.
Kang J; Chen J; Shi Y; Jia J; Zhang Y
Biochem Pharmacol; 2005 Apr; 69(8):1205-13. PubMed ID: 15794941
[TBL] [Abstract][Full Text] [Related]
6. Curcumin-induced apoptosis in ovarian carcinoma cells is p53-independent and involves p38 mitogen-activated protein kinase activation and downregulation of Bcl-2 and survivin expression and Akt signaling.
Watson JL; Greenshields A; Hill R; Hilchie A; Lee PW; Giacomantonio CA; Hoskin DW
Mol Carcinog; 2010 Jan; 49(1):13-24. PubMed ID: 19676105
[TBL] [Abstract][Full Text] [Related]
7. Curcumin protects against hyperosmoticity-induced IL-1beta elevation in human corneal epithelial cell via MAPK pathways.
Chen M; Hu DN; Pan Z; Lu CW; Xue CY; Aass I
Exp Eye Res; 2010 Mar; 90(3):437-43. PubMed ID: 20026325
[TBL] [Abstract][Full Text] [Related]
8. Curcumin-induced cell cycle arrest and apoptosis in human acute promyelocytic leukemia HL-60 cells via MMP changes and caspase-3 activation.
Tan TW; Tsai HR; Lu HF; Lin HL; Tsou MF; Lin YT; Tsai HY; Chen YF; Chung JG
Anticancer Res; 2006; 26(6B):4361-71. PubMed ID: 17201156
[TBL] [Abstract][Full Text] [Related]
9. Antileukemic activity of the combination of ionizing radiation with valproic acid in promyelocytic leukemia cells HL-60.
Rezacova M; Zaskodova D; Vavrova J; Vokurkova D; Tichy A
Neoplasma; 2008; 55(6):519-25. PubMed ID: 18999881
[TBL] [Abstract][Full Text] [Related]
10. Curcumin stimulates reactive oxygen species production and potentiates apoptosis induction by the antitumor drugs arsenic trioxide and lonidamine in human myeloid leukemia cell lines.
Sánchez Y; Simón GP; Calviño E; de Blas E; Aller P
J Pharmacol Exp Ther; 2010 Oct; 335(1):114-23. PubMed ID: 20605902
[TBL] [Abstract][Full Text] [Related]
11. Increased replication of human cytomegalovirus in retinal pigment epithelial cells by valproic acid depends on histone deacetylase inhibition.
Michaelis M; Suhan T; Reinisch A; Reisenauer A; Fleckenstein C; Eikel D; Gümbel H; Doerr HW; Nau H; Cinatl J
Invest Ophthalmol Vis Sci; 2005 Sep; 46(9):3451-7. PubMed ID: 16123451
[TBL] [Abstract][Full Text] [Related]
12. The role of p38 MAPK and JNK in Arsenic trioxide-induced mitochondrial cell death in human cervical cancer cells.
Kang YH; Lee SJ
J Cell Physiol; 2008 Oct; 217(1):23-33. PubMed ID: 18412143
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of c-Myc is critical for valproic acid-induced growth arrest and myeloid differentiation of acute myeloid leukemia.
Cheng YC; Lin H; Huang MJ; Chow JM; Lin S; Liu HE
Leuk Res; 2007 Oct; 31(10):1403-11. PubMed ID: 17445886
[TBL] [Abstract][Full Text] [Related]
14. [Effect of curcumin on acetylation of histone H3 in human lymphoma cell line Raji].
Li XG; Chen Y; Wu Q; Sun CY
Ai Zheng; 2006 May; 25(5):582-6. PubMed ID: 16687078
[TBL] [Abstract][Full Text] [Related]
15. Induction of differentiation and suppression of malignant phenotype of human neuroblastoma BE(2)-C cells by valproic acid: enhancement by combination with interferon-alpha.
Cinatl J; Kotchetkov R; Blaheta R; Driever PH; Vogel JU; Cinatl J
Int J Oncol; 2002 Jan; 20(1):97-106. PubMed ID: 11743648
[TBL] [Abstract][Full Text] [Related]
16. Histone deacetylase inhibitors promote osteoblast maturation.
Schroeder TM; Westendorf JJ
J Bone Miner Res; 2005 Dec; 20(12):2254-63. PubMed ID: 16294278
[TBL] [Abstract][Full Text] [Related]
17. The histone deacetylase inhibitors suberoylanilide hydroxamic (Vorinostat) and valproic acid induce irreversible and MDR1-independent resistance in human colon cancer cells.
Fedier A; Dedes KJ; Imesch P; Von Bueren AO; Fink D
Int J Oncol; 2007 Sep; 31(3):633-41. PubMed ID: 17671692
[TBL] [Abstract][Full Text] [Related]
18. Acyclic retinoid synergises with valproic acid to inhibit growth in human hepatocellular carcinoma cells.
Tatebe H; Shimizu M; Shirakami Y; Sakai H; Yasuda Y; Tsurumi H; Moriwaki H
Cancer Lett; 2009 Nov; 285(2):210-7. PubMed ID: 19520494
[TBL] [Abstract][Full Text] [Related]
19. Response of retinoic acid-resistant KG1 cells to combination of retinoic acid with diverse histone deacetylase inhibitors.
Savickiene J; Treigyte G; Magnusson KE; Navakauskiene R
Ann N Y Acad Sci; 2009 Aug; 1171():321-33. PubMed ID: 19723072
[TBL] [Abstract][Full Text] [Related]
20. Antileukemia activity of the combination of 5-aza-2'-deoxycytidine with valproic acid.
Yang H; Hoshino K; Sanchez-Gonzalez B; Kantarjian H; Garcia-Manero G
Leuk Res; 2005 Jul; 29(7):739-48. PubMed ID: 15927669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
